$ELUT
ELUTIA INC.

2021 Q4 Form 10-K Financial Statement

#000155837022003073 Filed on March 08, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $10.86M $47.39M $12.47M
YoY Change -12.9% 11.03% 3.49%
Cost Of Revenue $7.471M $28.37M $6.450M
YoY Change 15.83% 28.24% -9.92%
Gross Profit $3.390M $19.02M $6.020M
YoY Change -43.69% -7.49% 23.11%
Gross Profit Margin 31.21% 40.14% 48.28%
Selling, General & Admin $7.776M $32.79M $8.710M
YoY Change -10.72% 16.24% 17.07%
% of Gross Profit 229.38% 172.37% 144.68%
Research & Development $3.376M $9.266M $1.270M
YoY Change 165.83% 55.63% 92.42%
% of Gross Profit 99.59% 48.71% 21.1%
Depreciation & Amortization $933.0K $3.730M $940.0K
YoY Change -0.74% -3.47% -3.09%
% of Gross Profit 27.52% 19.61% 15.61%
Operating Expenses $11.15M $42.05M $9.980M
YoY Change 11.74% 23.11% 23.21%
Operating Profit -$7.762M -$23.03M -$3.960M
YoY Change 96.01% 69.37% 23.36%
Interest Expense -$1.290M $5.324M -$1.390M
YoY Change -7.19% -5.49% -4.14%
% of Operating Profit
Other Income/Expense, Net $0.00 $3.579M $0.00
YoY Change -239.42% -100.0%
Pretax Income -$9.052M -$24.78M -$5.350M
YoY Change 69.2% 13.66% 93.14%
Income Tax $12.00K $55.00K $10.00K
% Of Pretax Income
Net Earnings -$9.064M -$24.83M -$5.360M
YoY Change 69.1% 13.78% 92.81%
Net Earnings / Revenue -83.45% -52.4% -42.98%
Basic Earnings Per Share -$2.38
Diluted Earnings Per Share -$817.4K -$2.38 -$523.9K
COMMON SHARES
Basic Shares Outstanding 10.44M
Diluted Shares Outstanding 10.44M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.39M $30.39M $39.15M
YoY Change -22.37% -22.37%
Cash & Equivalents $30.39M $39.15M
Short-Term Investments
Other Short-Term Assets $1.485M $1.485M $3.270M
YoY Change -54.59% -54.59%
Inventory $9.554M $9.554M $10.12M
Prepaid Expenses
Receivables $5.996M $5.996M $7.166M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $47.43M $47.43M $59.71M
YoY Change -20.57% -20.57%
LONG-TERM ASSETS
Property, Plant & Equipment $1.200M $1.200M $1.162M
YoY Change 3.27% 3.45%
Goodwill
YoY Change
Intangibles $18.47M $21.87M
YoY Change -15.55%
Long-Term Investments
YoY Change
Other Assets $76.00K $76.00K $76.00K
YoY Change 0.0% -5.0%
Total Long-Term Assets $19.74M $19.74M $23.10M
YoY Change -14.55% -14.54%
TOTAL ASSETS
Total Short-Term Assets $47.43M $47.43M $59.71M
Total Long-Term Assets $19.74M $19.74M $23.10M
Total Assets $67.17M $67.17M $82.81M
YoY Change -18.89% -18.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.582M $1.582M $2.054M
YoY Change -22.98% -22.83%
Accrued Expenses $6.375M $6.375M $6.323M
YoY Change 0.82% 0.87%
Deferred Revenue
YoY Change
Short-Term Debt $8.059M $4.763M $6.310M
YoY Change 27.72% -26.84%
Long-Term Debt Due $8.059M $8.059M $6.310M
YoY Change 27.72% 27.72%
Total Short-Term Liabilities $26.00M $26.00M $26.78M
YoY Change -2.91% -2.91%
LONG-TERM LIABILITIES
Long-Term Debt $10.41M $10.41M $17.81M
YoY Change -41.55% -41.55%
Other Long-Term Liabilities $698.0K $17.24M $756.0K
YoY Change -7.67% -0.87%
Total Long-Term Liabilities $11.11M $27.65M $18.57M
YoY Change -40.17% -21.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.00M $26.00M $26.78M
Total Long-Term Liabilities $11.11M $27.65M $18.57M
Total Liabilities $53.65M $53.65M $61.98M
YoY Change -13.44% -13.44%
SHAREHOLDERS EQUITY
Retained Earnings -$105.1M -$80.26M
YoY Change 30.94%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.52M $13.52M $20.83M
YoY Change
Total Liabilities & Shareholders Equity $67.17M $67.17M $82.81M
YoY Change -18.89% -18.89%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$9.064M -$24.83M -$5.360M
YoY Change 69.1% 13.78% 92.81%
Depreciation, Depletion And Amortization $933.0K $3.730M $940.0K
YoY Change -0.74% -3.47% -3.09%
Cash From Operating Activities -$6.387M -$15.45M -$5.370M
YoY Change 18.94% 13.36% 108.14%
INVESTING ACTIVITIES
Capital Expenditures -$25.00K $369.0K -$110.0K
YoY Change -77.27% -42.34% -31.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$25.00K -$369.0K -$110.0K
YoY Change -77.27% -42.34% -31.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $43.00M
YoY Change
Debt Paid & Issued, Net $2.778M
YoY Change 826.0%
Cash From Financing Activities 14.21M 6.711M 43.37M
YoY Change -67.23% -86.89% 814.98%
NET CHANGE
Cash From Operating Activities -6.387M -15.45M -5.370M
Cash From Investing Activities -25.00K -369.0K -110.0K
Cash From Financing Activities 14.21M 6.711M 43.37M
Net Change In Cash 7.802M -9.104M 37.89M
YoY Change -79.41% -124.64% 1794.5%
FREE CASH FLOW
Cash From Operating Activities -$6.387M -$15.45M -$5.370M
Capital Expenditures -$25.00K $369.0K -$110.0K
Free Cash Flow -$6.362M -$15.82M -$5.260M
YoY Change 20.95% 10.86% 117.36%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
35000
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10444767
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2852541
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001708527
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10444767
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2852541
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.38
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.88
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
3400000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.88
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39577
CY2021 dei Entity Registrant Name
EntityRegistrantName
Aziyo Biologics, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4790334
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
12510 Prosperity Drive
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 370
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Silver Spring
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20904
CY2021 dei City Area Code
CityAreaCode
240
CY2021 dei Local Phone Number
LocalPhoneNumber
247-1170
CY2021 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.001 per share
CY2021 dei Trading Symbol
TradingSymbol
AZYO
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30428000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20831000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30393000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39150000
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
28649130
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Auditor Location
AuditorLocation
Baltimore, Maryland
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30393000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
39150000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
35000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
382000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5996000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7166000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9554000
CY2020Q4 us-gaap Inventory Net
InventoryNet
10117000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1450000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2892000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
47428000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
59707000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1200000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1162000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18466000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21865000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
76000
CY2021Q4 us-gaap Assets
Assets
67170000
CY2020Q4 us-gaap Assets
Assets
82810000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1582000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2054000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6375000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6323000
CY2021Q4 azyo Payables To Tissue Suppliers Current
PayablesToTissueSuppliersCurrent
2467000
CY2020Q4 azyo Payables To Tissue Suppliers Current
PayablesToTissueSuppliersCurrent
2295000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
8059000
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
6310000
CY2021Q4 azyo Revenue Interest Obligation Current
RevenueInterestObligationCurrent
2750000
CY2020Q4 azyo Revenue Interest Obligation Current
RevenueInterestObligationCurrent
2750000
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4763000
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
6514000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
533000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26001000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26779000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10410000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17811000
CY2021Q4 azyo Revenue Interest Obligation Noncurrent
RevenueInterestObligationNoncurrent
16540000
CY2020Q4 azyo Revenue Interest Obligation Noncurrent
RevenueInterestObligationNoncurrent
16633000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
698000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
756000
CY2021Q4 us-gaap Liabilities
Liabilities
53649000
CY2020Q4 us-gaap Liabilities
Liabilities
61979000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
118599000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
26000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
208000
CY2021 us-gaap Operating Expenses
OperatingExpenses
42054000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3535000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
101080000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105091000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-80259000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13521000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20831000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67170000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
82810000
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47390000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42682000
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
28368000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
22121000
CY2021 us-gaap Gross Profit
GrossProfit
19022000
CY2020 us-gaap Gross Profit
GrossProfit
20561000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18825000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17565000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13963000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10641000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9266000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5954000
CY2020 us-gaap Operating Expenses
OperatingExpenses
34160000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-23032000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-13599000
CY2021 us-gaap Interest Expense
InterestExpense
5324000
CY2020 us-gaap Interest Expense
InterestExpense
5633000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3579000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2567000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24777000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21799000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-24832000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-21825000
CY2020 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3510000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24832000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25335000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.38
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.88
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10444767
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2852541
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-55111000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2000
CY2020 us-gaap Preferred Stock Accretion Of Redemption Discount
PreferredStockAccretionOfRedemptionDiscount
3510000
CY2020 azyo Preferred Stock Warrant Exercises Value
PreferredStockWarrantExercisesValue
474000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
56998000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
43024000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
779000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-21825000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-24832000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13521000
CY2021 us-gaap Profit Loss
ProfitLoss
-24832000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2927000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1442000
CY2020 us-gaap Profit Loss
ProfitLoss
-21825000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3730000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3864000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
3029000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2340000
CY2020 azyo Gain Loss On Revaluation Of Revenue Interest Obligation And Other
GainLossOnRevaluationOfRevenueInterestObligationAndOther
-227000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
121000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
121000
CY2021 azyo Interest Expense Recorded As Additional Revenue Interest Obligation
InterestExpenseRecordedAsAdditionalRevenueInterestObligation
2654000
CY2020 azyo Interest Expense Recorded As Additional Revenue Interest Obligation
InterestExpenseRecordedAsAdditionalRevenueInterestObligation
2682000
CY2020 azyo Interest Expense Recorded As Convertible Preferred Stock
InterestExpenseRecordedAsConvertiblePreferredStock
39000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3535000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
779000
CY2020 us-gaap Other Noncash Expense
OtherNoncashExpense
814000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1170000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-64000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-563000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1455000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-420000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1907000
CY2021 azyo Increase Decrease In Obligations To Tissue Suppliers
IncreaseDecreaseInObligationsToTissueSuppliers
172000
CY2020 azyo Increase Decrease In Obligations To Tissue Suppliers
IncreaseDecreaseInObligationsToTissueSuppliers
-191000
CY2021 azyo Increase Decrease In Contract With Customer Liability And Other Liabilities
IncreaseDecreaseInContractWithCustomerLiabilityAndOtherLiabilities
-552000
CY2020 azyo Increase Decrease In Contract With Customer Liability And Other Liabilities
IncreaseDecreaseInContractWithCustomerLiabilityAndOtherLiabilities
-65000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15446000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13626000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
369000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
640000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-369000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-640000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
43024000
CY2021 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
13753000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
405000
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2000000
CY2021 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-1751000
CY2020 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
2286000
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
3441000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
26000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2000
CY2020 us-gaap Proceeds From Issuance Of Other Long Term Debt
ProceedsFromIssuanceOfOtherLongTermDebt
2995000
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2778000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
300000
CY2021 azyo Payments On Revenue Interest Obligation
PaymentsOnRevenueInterestObligation
2747000
CY2020 azyo Payments On Revenue Interest Obligation
PaymentsOnRevenueInterestObligation
2645000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
208000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6711000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51208000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2590000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
382000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9104000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
36942000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39532000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30428000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39532000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
4984000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
5113000
CY2020 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2000000
CY2021 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
3029000
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
13.9549
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2941176
CY2020Q4 us-gaap Share Price
SharePrice
17.00
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43000000.0
CY2020Q4 us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
3500000
CY2020Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3500000
CY2021 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Reclassifications</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">Certain reclassifications have been made to prior year amounts to conform with current year financial statement presentation.  The reclassifications relate to certain executive compensation costs and technical operations expenses at the Company’s Richmond, California plant. As follows are the total amounts reclassified for the year ended December 31, 2020 along with the line items in the Consolidated Statement of Operations that were impacted (in thousands).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:80%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></td></tr><tr style="height:18.05pt;"><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">    </b></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:26.56%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Increase (Decrease) From</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Previously Reported Amounts</b></p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sales and marketing</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.45pt 0.05pt 0pt;"> 720</p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">General and administrative</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.9%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"> (2,591)</p></td></tr><tr><td style="vertical-align:bottom;width:71.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Research and development</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:24.9%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3.45pt 0.05pt 0pt;"> 1,871</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 10pt 0pt;">These reclassifications did not impact the Company’s consolidated earnings or assets for the year ended December 31, 2020.</p>
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates and assumptions relating to inventories, receivables, long-lived assets, the valuation of stock-based awards, the valuation of the revenue interest obligation and deferred income taxes are made at the end of each financial reporting period by management. Management continually re-evaluates its estimates, judgments and assumptions, and management's evaluation could change. Actual results could differ from those estimates.</p>
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
39532000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
100000
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. At December 31, 2021 and 2020, the Company maintained $30.9 million and $40.0 million, respectively, in bank deposit accounts that are in excess of the $0.25 million insurance provided by the Federal Deposit Insurance Corporation in one federally insured financial institution. The Company has not experienced any losses in such accounts.</p>
CY2021Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
30900000
CY2020Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
40000000.0
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3535000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
779000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0096
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0050
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.64
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.55
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
834000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
708000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
6840000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7902000
CY2021Q4 us-gaap Inventory Net
InventoryNet
9554000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1880000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1507000
CY2020Q4 us-gaap Inventory Net
InventoryNet
10117000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5640000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5522000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4440000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4360000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1200000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1162000
CY2021 us-gaap Depreciation
Depreciation
300000
CY2020 us-gaap Depreciation
Depreciation
500000
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
100000
CY2020 us-gaap Cost Of Goods And Services Sold Depreciation
CostOfGoodsAndServicesSoldDepreciation
300000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34040000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15574000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18466000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
34040000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12175000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21865000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3400000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3400000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8059000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6667000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3889000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
18615000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
146000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
18469000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8059000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10410000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
24409000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18555000
CY2020Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1248000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.011
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.031
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.030
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.251
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.158
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.002
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2021Q4 azyo Deferred Tax Assets Goodwill
DeferredTaxAssetsGoodwill
3267000
CY2020Q4 azyo Deferred Tax Assets Goodwill
DeferredTaxAssetsGoodwill
3428000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14794000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
10008000
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
647000
CY2020Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
949000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
131000
CY2021Q4 azyo Deferred Tax Assets Acquired Intangible Assets
DeferredTaxAssetsAcquiredIntangibleAssets
1174000
CY2020Q4 azyo Deferred Tax Assets Acquired Intangible Assets
DeferredTaxAssetsAcquiredIntangibleAssets
908000
CY2021Q4 azyo Deferred Tax Assets Revenue Interest Obligation
DeferredTaxAssetsRevenueInterestObligation
1347000
CY2020Q4 azyo Deferred Tax Assets Revenue Interest Obligation
DeferredTaxAssetsRevenueInterestObligation
789000
CY2021Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
1866000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1314000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1094000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
200000
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
556000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
200000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
556000
CY2021Q4 azyo Deferred Tax Assets Net Of Liabilities
DeferredTaxAssetsNetOfLiabilities
24209000
CY2020Q4 azyo Deferred Tax Assets Net Of Liabilities
DeferredTaxAssetsNetOfLiabilities
17999000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24209000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
17999000
CY2021 azyo Deferred Tax Assets Change
DeferredTaxAssetsChange
6200000
CY2020 azyo Deferred Tax Assets Change
DeferredTaxAssetsChange
3600000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021 azyo Sale Of Stocks Payable Upon Consummation
SaleOfStocksPayableUponConsummation
750000
us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
400000
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
200000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24832000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25335000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10444767
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2852541
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.88
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1622796
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1065320
CY2021 azyo Number Of Production Facilities Under Operating Lease
NumberOfProductionFacilitiesUnderOperatingLease
2
CY2021 azyo Number Of Administrative And Research Facility Under Operating Lease
NumberOfAdministrativeAndResearchFacilityUnderOperatingLease
1
CY2021 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1200000
CY2020 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1100000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1175000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
998000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
781000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
594000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3548000
CY2021 us-gaap Loss Contingency New Claims Filed Number
LossContingencyNewClaimsFiledNumber
45
CY2021Q4 azyo Number Of Claims Recall No Lawsuit
NumberOfClaimsRecallNoLawsuit
42
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
47390000
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
42682000

Files In Submission

Name View Source Status
0001558370-22-003073-index-headers.html Edgar Link pending
0001558370-22-003073-index.html Edgar Link pending
0001558370-22-003073.txt Edgar Link pending
0001558370-22-003073-xbrl.zip Edgar Link pending
azyo-20211231.xsd Edgar Link pending
azyo-20211231x10k.htm Edgar Link pending
azyo-20211231x10k004.jpg Edgar Link pending
azyo-20211231x10k005.jpg Edgar Link pending
azyo-20211231x10k006.jpg Edgar Link pending
azyo-20211231x10k007.jpg Edgar Link pending
azyo-20211231x10k008.jpg Edgar Link pending
azyo-20211231x10k_htm.xml Edgar Link completed
azyo-20211231xex10d3.htm Edgar Link pending
azyo-20211231xex10d4.htm Edgar Link pending
azyo-20211231xex21d1.htm Edgar Link pending
azyo-20211231xex23d1.htm Edgar Link pending
azyo-20211231xex31d1.htm Edgar Link pending
azyo-20211231xex31d2.htm Edgar Link pending
azyo-20211231xex32d1.htm Edgar Link pending
azyo-20211231xex32d2.htm Edgar Link pending
azyo-20211231_cal.xml Edgar Link unprocessable
azyo-20211231_def.xml Edgar Link unprocessable
azyo-20211231_lab.xml Edgar Link unprocessable
azyo-20211231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending